1. Home
  2. NSYS vs MIRA Comparison

NSYS vs MIRA Comparison

Compare NSYS & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nortech Systems Incorporated

NSYS

Nortech Systems Incorporated

HOLD

Current Price

$16.18

Market Cap

41.7M

Sector

Technology

ML Signal

HOLD

Logo MIRA Pharmaceuticals Inc.

MIRA

MIRA Pharmaceuticals Inc.

HOLD

Current Price

$0.97

Market Cap

43.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSYS
MIRA
Founded
1981
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.7M
43.7M
IPO Year
1996
2023

Fundamental Metrics

Financial Performance
Metric
NSYS
MIRA
Price
$16.18
$0.97
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
29.6K
123.9K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
80.85
N/A
EPS
N/A
N/A
Revenue
$14,371,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.01
N/A
52 Week Low
$6.50
$0.90
52 Week High
$18.01
$2.45

Technical Indicators

Market Signals
Indicator
NSYS
MIRA
Relative Strength Index (RSI) 63.31 44.02
Support Level $8.62 $0.91
Resistance Level $18.01 $1.22
Average True Range (ATR) 1.35 0.06
MACD 0.23 -0.00
Stochastic Oscillator 87.90 8.04

Price Performance

Historical Comparison
NSYS
MIRA

About NSYS Nortech Systems Incorporated

Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.

Share on Social Networks: